Clinical Trials Browser

INDUSTRY × Stomach Neoplasms × Pharmaceutical Preparations × Clear all

NCT07364422 2026-01-23

To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms